Rare Diseases - Blockbuster in the niche
Around 30 million Europeans are affected by a rare disease. Although some rare diseases have life-threatening consequences, this market has just recently attracted the attention of the Pharma Industry. This trend to personalised medicine gives hope to all patients who suffer from a rare disease.
Leading experts in drug development, clinical trials and representatives from all major biotech companies met at the 4th annual Berlin Conference which was held on February 18 at the Spanish Embassy to discuss the latest trends in orphan drug development. The conference was organised by the event manager BIOCOM.